R. Jyothirmayi

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 599 citations · Full text

Primary Tumour Subtype, Epidemiology, Cancer Epidemiology +11

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

Stephen Johnston, Lucy Kilburn, David Dodwell et al. · The Lancet Oncology · 2013 · 272 citations · Full text

Radiotherapy in the treatment of solitary plasmacytoma.

R. Jyothirmayi, V. P. Gangadharan, Nair Mk et al. · British Journal of Radiology · 1997 · 99 citations

Local Control, Neuro-oncology, Hematological Malignancy +14

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial

Galina Velikova, Linda Williams, Sarah Willis et al. · The Lancet Oncology · 2018 · 80 citations · Full text

Quality Of Life, Surgical Oncology, Radiation Therapy +11

Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma

R. Jyothirmayi, Jayaprakash Madhavan, Madhavan Krishnan Nair et al. · Journal of Neuro-Oncology · 1997 · 73 citations